Search

Your search keyword '"Sensintaffar, John L."' showing total 24 results

Search Constraints

Start Over You searched for: Author "Sensintaffar, John L." Remove constraint Author: "Sensintaffar, John L."
24 results on '"Sensintaffar, John L."'

Search Results

1. Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors.

3. Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors

4. Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models

5. Discovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors

6. Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models.

7. Discovery and Structure-Based Optimization of Potent and Selective WDR5 Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core

8. Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core

9. Abstract 3987: Predicting MCL1 inhibitor sensitivity in large cell line panels using a gene expression signature

10. Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer

11. Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design

12. Discovery and Biological Characterization of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors

13. Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core

14. Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In VivoActivities in Mouse Models of Hematological and Solid Tumors

15. Discovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors

16. Abstract 3551: Discovery of orally bioavailable novel Mcl-1 inhibitors that exhibit selective anti-proliferative activity in Mcl-1 sensitive cancer cell lines

18. Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods

19. BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90

20. Rationally Designed High-Affinity 2-Amino-6-halopurine Heat Shock Protein 90 Inhibitors That Exhibit Potent Antitumor Activity

21. 7‘-Substituted Benzothiazolothio- and Pyridinothiazolothio-Purines as Potent Heat Shock Protein 90 Inhibitors

22. Orally Active Purine-Based Inhibitors of the Heat Shock Protein 90

23. Fragment-Based Screen of SARS-CoV-2 Papain-like Protease (PL pro ).

24. Orally active purine-based inhibitors of the heat shock protein 90.

Catalog

Books, media, physical & digital resources